Ginger Healthcare connects you with leading hematology specialists in India for expert diagnosis and treatment of blood disorders, cancers, and stem cell transplants.
Hematology is a specialized field of medicine focused on diagnosing, treating, and managing disorders affecting the blood, bone marrow, lymphatic system, and blood-clotting process. Blood plays an essential role in carrying oxygen, fighting infections, controlling bleeding, and supporting the body’s overall function. Hematologists are trained to manage both non-cancerous blood disorders and blood-related cancers through accurate diagnosis and personalized treatment planning.
Hematological conditions may affect red blood cells, white blood cells, platelets, clotting proteins, or the bone marrow where blood cells are produced. Common non-cancerous conditions include anaemia, thalassemia, sickle cell disease, haemophilia, low platelet counts, bleeding disorders, and abnormal blood clots. Hematologists also treat blood cancers such as leukaemia, lymphoma, and multiple myeloma, which require specialised and coordinated medical care.
Diagnosis usually involves blood tests such as a complete blood count, blood-smear examination, clotting studies, iron and vitamin tests, genetic testing, and specialised laboratory investigations. In certain cases, a bone marrow aspiration or biopsy may be required to assess blood-cell production and identify bone marrow disorders or blood cancers. Imaging tests and lymph-node biopsies may also be recommended when lymphoma or other lymphatic conditions are suspected.
Treatment depends on the type, severity, and cause of the blood disorder. Options may include iron or vitamin supplements, medicines, blood or platelet transfusions, clotting-factor replacement, anticoagulants, chemotherapy, immunotherapy, targeted therapy, and stem cell or bone marrow transplantation. Some inherited or chronic blood conditions may require regular monitoring, repeated transfusions, or long-term medication to prevent complications.
With advances in laboratory testing, genetic diagnosis, targeted medicines, and transplant techniques, many blood disorders can now be managed more effectively. Experienced hematologists work with oncologists, transplant specialists, pathologists, and supportive-care teams to provide comprehensive care. The main aim of hematology treatment is to restore healthy blood-cell production, control bleeding or clotting problems, treat blood cancers, prevent complications, and improve the patient’s overall health and quality of life.
Explore procedures, recovery times, and what to expect from each treatment
Lymphoma is a cancer of the lymphatic system, the network that helps your body fight infection. It includes Hodgkin and non-Hodgkin types, each with several subtypes. Treatment may involve chemotherapy, immunotherapy, targeted drugs, radiation, or stem cell transplant, depending on the subtype and stage.
Learn more →
Thalassemia is an inherited blood disorder in which the body makes less haemoglobin than normal, leading to anaemia. Care ranges from monitoring in mild forms to lifelong transfusions, iron chelation, and bone marrow transplant in severe forms. Treatment is shaped by the type and severity.
Learn more →
Multiple myeloma is a cancer of plasma cells in the bone marrow that can affect bones, blood counts, kidneys, and immunity. Modern treatment combines targeted drugs, immunotherapy, and sometimes a stem cell transplant. It is usually managed as a long-term condition with periods of remission and relapse.
Learn more →
Bone marrow transplant (BMT), also called hematopoietic stem cell transplant, replaces damaged or diseased bone marrow with healthy blood-forming stem cells. It is used for blood cancers, marrow failure, inherited blood disorders, and immune deficiencies. The process unfolds over months and involves several distinct stages.
Learn more →
Sickle cell disease is an inherited blood disorder in which red blood cells become rigid and crescent-shaped, blocking small vessels and causing pain, anaemia, and organ damage over time. Care combines preventive measures, disease-modifying medication, transfusions, and, for some patients, curative stem cell transplant or gene therapy.
Learn more →
Blood cancer treatment covers care for leukemia, lymphoma, and myeloma. It uses chemotherapy, targeted therapy, immunotherapy, radiation, and stem cell transplant, often in combination. The right plan depends on the specific diagnosis, disease stage or risk group, and individual health factors.
Learn more →
Acute leukemia is a fast-developing blood cancer in which abnormal immature white blood cells crowd out healthy blood production. The two main forms are acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Treatment is intensive and multi-phase, often including chemotherapy and, for some patients, stem cell transplant.
Learn more →
Autologous stem cell transplant is a treatment that uses a patient’s own blood-forming stem cells to restore bone marrow after high-dose chemotherapy. It is most often used for multiple myeloma and certain lymphomas. The process unfolds across several weeks and recovery continues for many months.
Learn more →
Chronic leukemia is a slow-growing blood cancer that begins in the bone marrow and causes a build-up of abnormal white blood cells. The two main types — chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) — are treated differently and are often managed for many years.
Learn more →
Chronic thrombocytopenia is a long-term condition of persistently low platelets, most often caused by chronic immune thrombocytopenia (ITP). Treatment focuses on raising platelet counts safely and reducing bleeding risk using medications, immune-modulating therapy, or splenectomy when needed.
Learn more →
A haploidentical bone marrow transplant uses stem cells from a half-matched family donor — usually a parent, child, or sibling — when no fully matched donor is available. It is used to treat leukaemias, lymphomas, aplastic anaemia, and other serious blood disorders. The process unfolds over many months and involves conditioning, stem cell infusion, and careful immune recovery.
Learn more →
Hemophilia is an inherited bleeding disorder caused by a missing or reduced clotting factor, most often factor VIII (hemophilia A) or factor IX (hemophilia B). Management focuses on preventing bleeds, treating them quickly when they happen, and protecting joints over a lifetime. Treatment may include factor replacement, non-factor therapies, gene therapy, and supportive care.
Learn more →
Myelodysplastic syndromes (MDS) are a group of bone marrow disorders in which blood cells are not made properly, leading to low blood counts and a risk of progression to acute leukaemia. Treatment is guided by risk group and ranges from supportive care and drug therapy to allogeneic stem cell transplant in selected patients.
Learn more →
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder in which red blood cells break down too easily, causing anaemia, fatigue, dark urine, and a high risk of blood clots. Treatment ranges from supportive care and targeted complement inhibitor medication to bone marrow transplant in selected cases.
Learn more →
Plasmapheresis, also called plasma exchange, is a procedure that removes harmful substances from the blood by separating and replacing the plasma. It is used for certain autoimmune, neurological, kidney, and blood disorders. Treatment is usually given as a series of sessions, and the right approach depends on the underlying condition.
Learn more →
Von Willebrand disease (VWD) is the most common inherited bleeding disorder, caused by missing or faulty von Willebrand factor. Management ranges from no daily treatment for mild cases to scheduled therapy for surgeries, periods, and severe bleeding. The right plan depends on the VWD type, severity, and life stage.
Learn more →Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
